1. Validation and Normative Data of the Spanish Version of the Face Name Associative Memory Exam (S-FNAME).
- Author
-
Alviarez-Schulze, Vanessa, Cattaneo, Gabriele, Pachón-García, Catherine, Solana-Sánchez, Javier, Tormos-Muñoz, Josep M., Alegret, Montserrat, Pascual-Leone, Alvaro, and Bartrés-Faz, David
- Subjects
- *
EPISODIC memory , *REFERENCE values , *PSYCHOMETRICS , *MEMORY disorders , *MIDDLE-aged persons , *MEMORY - Abstract
Objective: The relevance of the episodic memory in the prediction of brain aging is well known. The Face Name Associative Memory Exam (FNAME) is a valued associative memory measure related to Alzheimer's disease (AD) biomarkers, such as amyloid-β deposition preclinical AD individuals. Previous validation of the Spanish version of the FNAME test (S-FNAME) provided normative data and psychometric characteristics. The study was limited to subjects attending a memory clinic and included a reduced sample with gender inequality distribution. The purpose of this study was to assess S-FNAME psychometric properties and provide normative data in a larger independent sample of cognitively healthy individuals. Method: S-FNAME was administered to 511 cognitively healthy volunteers (242 women, aged 41–65 years) participating in the Barcelona Brain Health Initiative cohort study. Results: Factor analysis supported construct validity revealing two underlying components: face-name and face-occupation and explaining 95.34% of the total variance, with satisfactory goodness of fit. Correlations between S-FNAME and Rey Auditory-Verbal Learning Test were statistically significant and confirmed its convergent validity. We also found weak correlations with non-memory tests supporting divergent validity. Women showed better scores, and S-FNAME was positively correlated with education and negatively with age. Finally, we generated normative data. Conclusions: The S-FNAME test exhibits good psychometric properties, consistent with previous findings, resulting in a valid and reliable tool to assess episodic memory in cognitively healthy middle-aged adults. It is a promising test for the early detection of subtle memory dysfunction associated with abnormal brain aging. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF